LPL Financial’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.79M | Buy |
109,007
+4,105
| +4% | +$105K | ﹤0.01% | 2795 |
|
2025
Q1 | $2.88M | Buy |
104,902
+49,026
| +88% | +$1.35M | ﹤0.01% | 2597 |
|
2024
Q4 | $1.51M | Buy |
55,876
+4,776
| +9% | +$129K | ﹤0.01% | 3125 |
|
2024
Q3 | $1.47M | Sell |
51,100
-2,015
| -4% | -$58.1K | ﹤0.01% | 2984 |
|
2024
Q2 | $1.45M | Sell |
53,115
-8,533
| -14% | -$232K | ﹤0.01% | 2878 |
|
2024
Q1 | $1.73M | Sell |
61,648
-5,769
| -9% | -$162K | ﹤0.01% | 2642 |
|
2023
Q4 | $1.79M | Buy |
67,417
+5,900
| +10% | +$157K | ﹤0.01% | 2486 |
|
2023
Q3 | $1.57M | Sell |
61,517
-9,203
| -13% | -$235K | ﹤0.01% | 2503 |
|
2023
Q2 | $1.85M | Buy |
70,720
+595
| +0.8% | +$15.6K | ﹤0.01% | 2310 |
|
2023
Q1 | $1.83M | Sell |
70,125
-2,654
| -4% | -$69.3K | ﹤0.01% | 2210 |
|
2022
Q4 | $2M | Sell |
72,779
-7,430
| -9% | -$204K | ﹤0.01% | 2072 |
|
2022
Q3 | $1.93M | Buy |
80,209
+20,540
| +34% | +$494K | ﹤0.01% | 2015 |
|
2022
Q2 | $1.58M | Sell |
59,669
-9,037
| -13% | -$239K | ﹤0.01% | 2207 |
|
2022
Q1 | $1.83M | Buy |
68,706
+8,775
| +15% | +$233K | ﹤0.01% | 2118 |
|
2021
Q4 | $1.62M | Sell |
59,931
-2,461
| -4% | -$66.6K | ﹤0.01% | 2242 |
|
2021
Q3 | $1.61M | Sell |
62,392
-1,570
| -2% | -$40.5K | ﹤0.01% | 2217 |
|
2021
Q2 | $1.66M | Sell |
63,962
-7,620
| -11% | -$197K | ﹤0.01% | 2125 |
|
2021
Q1 | $1.83M | Buy |
71,582
+6,930
| +11% | +$177K | ﹤0.01% | 1903 |
|
2020
Q4 | $1.67M | Buy |
64,652
+9,003
| +16% | +$232K | ﹤0.01% | 1791 |
|
2020
Q3 | $1.34M | Sell |
55,649
-14,490
| -21% | -$349K | ﹤0.01% | 1703 |
|
2020
Q2 | $1.6M | Buy |
70,139
+56,651
| +420% | +$1.29M | ﹤0.01% | 1493 |
|
2020
Q1 | $262K | Sell |
13,488
-324
| -2% | -$6.29K | ﹤0.01% | 2596 |
|
2019
Q4 | $322K | Sell |
13,812
-1,253
| -8% | -$29.2K | ﹤0.01% | 2700 |
|
2019
Q3 | $307K | Sell |
15,065
-401
| -3% | -$8.17K | ﹤0.01% | 2650 |
|
2019
Q2 | $327K | Buy |
+15,466
| New | +$327K | ﹤0.01% | 2618 |
|